These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless? Chen G, Xue Y, Zhang Q, Xue T, Yao J, Huang H, Liang J, Li L, Lin W, Lin L, Shi L, Cai L, Wen J. J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199 [Abstract] [Full Text] [Related]
5. Normocalcemic Hyperparathyroidism. Corbetta S. Front Horm Res; 2019 Jun; 51():23-39. PubMed ID: 30641527 [Abstract] [Full Text] [Related]
8. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism. Cesareo R, Di Stasio E, Vescini F, Campagna G, Cianni R, Pasqualini V, Romitelli F, Grimaldi F, Manfrini S, Palermo A. Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023 [Abstract] [Full Text] [Related]
9. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism. Lemos ALP, Andrade SRL, Pontes LLH, Teixeira PMC, Bandeira E, Bandeira LC, Bandeira F. Kidney Blood Press Res; 2019 Apr; 44(5):1189-1195. PubMed ID: 31542783 [Abstract] [Full Text] [Related]
10. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, Borderie D, Kahan A, Cormier C. J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096 [Abstract] [Full Text] [Related]
11. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M, Cakal E. BMC Cardiovasc Disord; 2019 May 08; 19(1):106. PubMed ID: 31068134 [Abstract] [Full Text] [Related]
12. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. Tuna MM, Çalışkan M, Ünal M, Demirci T, Doğan BA, Küçükler K, Özbek M, Berker D, Delibaşı T, Güler S. J Bone Miner Metab; 2016 May 08; 34(3):331-5. PubMed ID: 26056016 [Abstract] [Full Text] [Related]
13. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels. Lui MS, Clemente-Gutierrez U, Vodopivec DM, Chang SL, Shirali AS, Huang BL, Chiang YJ, Fisher SB, Grubbs EG, Guise TA, Graham PH, Perrier ND. World J Surg; 2023 Feb 08; 47(2):363-370. PubMed ID: 36195677 [Abstract] [Full Text] [Related]
14. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism. Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D, Casini A, Pedone C, Lelli D, Fabbri A, Bilezikian JP, Napoli N, Pozzilli P, Manfrini S, Cesareo R. J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32271382 [Abstract] [Full Text] [Related]
16. Normocalcemic Primary Hyperparathyroidism in Adults Without a History of Nephrolithiasis or Fractures: A Prospective Study. Rosário PW, Calsolari MR. Horm Metab Res; 2019 Apr 01; 51(4):243-247. PubMed ID: 30840998 [Abstract] [Full Text] [Related]
17. Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management. Wu C, Gillis A, Lindeman B, Chen H, Fazendin J. Am J Surg; 2024 Sep 01; 235():115812. PubMed ID: 39002253 [Abstract] [Full Text] [Related]
18. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level. Chertok Shacham E, Maman N, Lazareva T, Masalha R, Mahagna L, Sela G, Ishay A. Front Endocrinol (Lausanne); 2023 Sep 01; 14():1152464. PubMed ID: 37065752 [Abstract] [Full Text] [Related]
19. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism. Choi HR, Choi SH, Hong N, Rhee Y, Kim JK, Lee CR, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY. J Korean Med Sci; 2022 Apr 04; 37(13):e99. PubMed ID: 35380024 [Abstract] [Full Text] [Related]
20. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. Maruani G, Hertig A, Paillard M, Houillier P. J Clin Endocrinol Metab; 2003 Oct 04; 88(10):4641-8. PubMed ID: 14557434 [Abstract] [Full Text] [Related] Page: [Next] [New Search]